After two successive years of gains, the Nifty Pharma index has been an underperformer so far in 2022. The index had rallied 60 per cent in 2020, and subsequently gained 10 per cent in 2021. So far in
Subscribe To Insights
What do you get on Business Standard Premium?
MONTHLY₹8/day
₹249₹249
SMART ANNUAL₹4/day
₹1499₹1499
Opt for auto renewal and save Rs 300
ANNUAL₹5/day
₹1799
What you get on Business Standard Premium?
-
Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
-
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.